MHRA Drug Safety Update – November 2018

MHRA Drug Safety Update – November 2018

November 14, 2018

Date issued: 14th November 2018

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 12 Issue 4, November 2018) has been published and includes articles on:

  • Hydrochlorthiazide: risk of non-melanoma skin cancer, particularly in long-term use.
  • Systemic and inhaled fluoroquinolones: small increased risk of aortic aneurysm and dissection; advice for prescribing in high risk patients.
  • Support Yellow Card: help improve the safety of medicines in pregnancy and breastfeeding, and in babies and children.

To sdee the latest MHRA Drug Safety Update in full, visit the GOV.uk website.

 



Posted in:


More Latest News >

PSNC Job Opportunity: Office Administrator

PSNC (the Pharmaceutical Services Negotiating Committee) represents England’s community (high-street) pharmacies, and is looking to recruit an Office Administrator to...